Air data systems market is projected to grow from $2.54 billion in 2025 to $3.94 billion by 2035, registering a CAGR of 4.5% during the forecast period. Air data systems, including air data computers (ADC), sensors, probes, and integrated avionics software, are essential for measuring altitude, airspeed, and environmental parameters, ensuring flight safety and operational efficiency across commercial, defense, and UAV platforms.

T-cell lymphoma market is projected to grow from $2.7 billion in 2025 to $5.1 billion by 2035, registering a CAGR of 6.5% during the forecast period. The market growth is primarily driven by the rising burden of cancer globally and increasing adoption of targeted and immunotherapies. According to the World Health Organization, cancer accounted for nearly 10 million deaths worldwide in 2022, with lymphomas representing a significant portion of hematological malignancies. Additionally, data from the International Agency for Research on Cancer highlights a steady increase in non-Hodgkin lymphoma incidence, which directly supports demand for advanced therapies targeting T-cell lymphoma subtypes such as PTCL and CTCL.

Telecommunication market was valued at $2.15 trillion in 2025 and is projected to reach $3.95 trillion by 2035, growing at a CAGR of 6.3% during the forecast period (2026–2035). The market includes wireless services, wireline services, and pay TV services, supported by evolving technologies such as 2G, 3G, 4G/LTE, and 5G. Telecommunications serves as the backbone of global digital infrastructure, enabling connectivity across residential, commercial, and government sectors.

Uveitis treatment market is projected to grow significantly from $1.90 billion in 2025 to $3.36 billion by 2035, registering a CAGR of 5.86% during the forecast period (2026–2035). The market expansion is primarily driven by the increasing global burden of inflammatory eye diseases, rising awareness regarding early diagnosis, and advancements in biologic therapies.

Urodynamic equipment and consumables market was valued at $462.0 million in 2025 and is expected to reach $771.8 million by 2035, expanding at a CAGR of 5.3% during the forecast period (2026–2035). The market growth is largely driven by the rising prevalence of urological disorders, including urinary incontinence and benign prostatic hyperplasia (BPH). A study published by the highlights the significant role of urodynamic testing in assessing lower urinary tract symptoms and supporting clinical decision-making. The research underscores that urodynamic studies provide detailed insights into bladder function, especially in complex or ambiguous cases. These diagnostic procedures are increasingly being adopted in clinical settings due to their accuracy and effectiveness. As a result, there is a growing demand for urodynamic tests across hospitals and speciality clinics. This trend is directly contributing to the increased use of consumables such as catheters, electrodes, and pressure monitoring lines. Additionally, the shift toward single-use disposable products to reduce infection risks is further supporting market expansion.

UK myocardial infarction market was valued at approximately $1.4 billion in 2025 and is projected to reach $2.3 billion by 2035, expanding at a CAGR of 5.5% during the forecast period from 2026 to 2035. This growth is primarily driven by the rising prevalence of cardiovascular diseases and increasing demand for advanced interventional and diagnostic solutions. According to the World Health Organization, cardiovascular diseases remain the leading cause of death globally, accounting for approximately 19.8 million deaths annually, with nearly 85% attributed to heart attacks and strokes. This significant disease burden reflects a growing incidence of myocardial infarction cases worldwide, including in developed healthcare systems such as the UK. As a result, demand for effective pharmacological therapies, minimally invasive interventional procedures, and advanced diagnostic technologies is increasing. 

Total ankle replacement market was valued at approximately $305.8 million in 2025 and is projected to reach $612.4 million by 2035, growing at a CAGR of 7.2% during the forecast period (2026–2035). This growth is primarily driven by the increasing prevalence of musculoskeletal disorders and the rising preference for motion-preserving orthopedic procedures. Advancements in implant design and surgical techniques have significantly improved the effectiveness of total ankle replacement (TAR). In December 2024, the Cleveland Clinic reported that TAR has become a viable treatment option for a broader patient population, including younger and more active individuals with end-stage ankle arthritis.

The single-use medical device reprocessing market was valued at 1.3 billion in 2025 and is projected to reach $2.8 billion by 2035, expanding at a CAGR of 8.0% from 2026 to 2035. This growth is primarily driven by rising healthcare expenditures and the increasing need to manage medical waste efficiently. Healthcare facilities are increasingly adopting reprocessing solutions to reduce costs while maintaining safety standards. According to the World Health Organization (WHO), nearly 15% of waste generated by healthcare activities is considered hazardous, highlighting the urgency for proper waste management practices. Reprocessing of single-use devices offers a sustainable approach by minimizing landfill waste and conserving resources.

Schizophrenia drugs market was valued at $10.2 billion in 2025 and is projected to reach $17.4 billion by 2035, growing at a CAGR of 5.6%. A key macro driver is the rising global burden of mental disorders, as highlighted by the OECD, which reports significantly higher mortality rates among individuals with schizophrenia compared to the general population. This underscores the urgent need for effective long-term treatment solutions and improved access to care. Additionally, a 2025 study published on PubMed Central indicates that current treatment options primarily focus on symptom management rather than cure, due to the complex and not fully understood nature of the disorder. Existing antipsychotic therapies mainly address positive symptoms such as hallucinations and delusions but are often associated with long-term side effects. 

Revenue assurance market is projected to grow from $3.2 billion in 2025 to $7.8 billion by 2035, expanding at a CAGR of 9.3% during 2026 to 2035. The growth is primarily driven by the rapid expansion of digital transactions and rising telecom data usage worldwide. According to the , nearly 6 billion people about 74% of the global population were using the internet. This surge in connectivity is significantly increasing data volumes, leading to greater billing complexity and higher risks of revenue leakage. As telecom ecosystems become more dynamic with 5G and digital services, enterprises are facing challenges in ensuring accurate revenue capture. Consequently, organizations are increasingly adopting advanced revenue assurance solutions to monitor transactions, detect anomalies, and safeguard profit margins.